跳至主要内容
临床试验/CTRI/2025/11/098021
CTRI/2025/11/098021尚未招募2 期

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Jatiphaladi Churna Vati And Trailokya Vijaya Vati In Opioid Use Disorders

National Institute of Ayurveda, Jaipur1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2026年3月2日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
42
试验地点
1

研究概览

简要总结

Opioid use disorders is a condition in which a person uses various forms of opium for addiction purpose. Currently Opioid replacement therapy is used with drugs such as methadone which produce some side effects. Hence an ayurvedic alternative is being explored. Trailokya Vijaya Vati has shown significant results in withdrawals produced due to opium. Both Jatiphaladi Churna Vati and Trailokya Vijaya Vati contains Bhanga in 50% quantity as an active ingredient which is useful in withdrawal symptoms. Hence a clinical trial is needed to establish comparison between these drugs

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient with COWS score ranging from 5-24 Patients of either sex Patients willing to give consent for clinical trial Age between 18-60 years.

排除标准

  • Patients having addiction other than Opium Patients with any type of psychiatric disorders, neurological disorders like Alzheimer’s disease, Parkinsonism, any type of Venereal diseases, any major systemic diseases like Carcinoma, Heart diseases, Hepatic and Renal failure, DM, unmanageable hypertension etc.
  • Patients who are receiving any contemporary de addiction treatment.

研究者

发起方
National Institute of Ayurveda, Jaipur
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Singh Pooja Jairam

National Institute of Ayurveda

研究点 (1)

Loading locations...

相似试验